CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2019

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

 

 

 

 

 

 

 

 

 

 

 

Anti-inflammatory and anti-lipemic effect of statin therapy in coronary artery disease patients with calcium calcification

Author: 
Noor N Nafie, Basil O Saleh and Sabah M Fadhil
Subject Area: 
Social Sciences and Humanities
Abstract: 

Background: Inflammation plays a central role in atherosclerosis. In multiple epidemiologic studies, inflammatory biomarkers such as high sensitive C-reactive protein (hs-CRP), has been associated with increased risk of coronary heart disease (CHD) and it has been directly implicated in the pathogenesis of atherosclerosis The present study was designed to show the anti-inflammatory and anti-lipemic effect of 6-8 months of statin treatment via the measurement of serum hs-CRP and lipid profile parameters. Subjects and Methods: This study was carried out at Biochemistry Department, College of Medicine, Baghdad University and at Ibn-Al-Bitar Hospital, Bagdad, Iraq, during the period from February 2013 to November 2013. It included 25 patients with coronary artery disease and who have had a mild to moderate coronary artery Ca score of < 400 agatston unit (AU) and not on statin treatment (GI). Twenty of these patients were putted on atrovastatin treatment for 6-8 months and regarded as GII. Investigations included serum measurement of high sensitive-(hs-) CRP, lipid profile parameters, fasting serum glucose and HbA1c in both groups. Results: After the complete course of treatment with statin, the mean value of hs-CRP concentration of GI (2.77±2.83 mg/l) was decreased in comparison to those before treatment of the same patients group (GII, 3.04±3.45 mg/l), but did not reach the significant level. The mean value of HDL-cholesterol and VLDL-cholesterol concentrations were significantly increased in GII when compared to GI (P=0.001, P= 0.019, respectively). The glycemic index measured by HbA1c and fasting glucose did not differ significantly between both groups. Conclusion: This study concluded the anti-inflammatory and anti-lipemic role of statin in coronary artery disease patients as reflected by significant increase of serum HDL-cholesterol. However, the insignificant effect of statin on serum hs-CRP concentration may need for longer period of its treatment.

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

 

 

 

 

 

 

 

 

 

 

 

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran